Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis

BACKGROUND: The overall response rate of immunotherapy in triple-negative breast cancer (TNBC) remains unsatisfactory. Accumulating evidence indicated that glucose metabolic reprogramming could modulate immunotherapy efficacy. However, transcriptomic evidence remains insufficient. METHODS: Genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tao, Liu, Jiahao, Xia, Yu, Wang, Zhi, Li, Xingrui, Gao, Qinglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604452/
https://www.ncbi.nlm.nih.gov/pubmed/34134578
http://dx.doi.org/10.1080/07853890.2021.1937694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604452/
https://www.ncbi.nlm.nih.gov/pubmed/34134578
http://dx.doi.org/10.1080/07853890.2021.1937694

Ejemplares similares